BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 12133004)

  • 1. Interactions of ATP, oestradiol, genistein and the anti-oestrogens, faslodex (ICI 182780) and tamoxifen, with the human erythrocyte glucose transporter, GLUT1.
    Afzal I; Cunningham P; Naftalin RJ
    Biochem J; 2002 Aug; 365(Pt 3):707-19. PubMed ID: 12133004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of GLUT1-mediated sugar transport by an antiport/uniport switch mechanism.
    Cloherty EK; Diamond DL; Heard KS; Carruthers A
    Biochemistry; 1996 Oct; 35(40):13231-9. PubMed ID: 8855962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human erythrocyte sugar transport is incompatible with available carrier models.
    Cloherty EK; Heard KS; Carruthers A
    Biochemistry; 1996 Aug; 35(32):10411-21. PubMed ID: 8756697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hexose transporter GLUT1 harbors several distinct regulatory binding sites for flavones and tyrphostins.
    Pérez A; Ojeda P; Ojeda L; Salas M; Rivas CI; Vera JC; Reyes AM
    Biochemistry; 2011 Oct; 50(41):8834-45. PubMed ID: 21899256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and physiologic determinants of human erythrocyte sugar transport regulation by adenosine triphosphate.
    Levine KB; Cloherty EK; Fidyk NJ; Carruthers A
    Biochemistry; 1998 Sep; 37(35):12221-32. PubMed ID: 9724536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The red blood cell glucose transporter presents multiple, nucleotide-sensitive sugar exit sites.
    Cloherty EK; Levine KB; Carruthers A
    Biochemistry; 2001 Dec; 40(51):15549-61. PubMed ID: 11747430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of Glut1 glucose transporter in human erythrocytes.
    Zhang JZ; Ismail-Beigi F
    Arch Biochem Biophys; 1998 Aug; 356(1):86-92. PubMed ID: 9681995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of anti-GLUT antibodies on glucose transport into human erythrocyte ghosts.
    Afzal I; Browning JA; Drew C; Ellory JC; Naftalin RJ; Wilkins RJ
    Bioelectrochemistry; 2004 May; 62(2):195-8. PubMed ID: 15039027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cooperative nucleotide binding to the human erythrocyte sugar transporter.
    Cloherty EK; Levine KB; Graybill C; Carruthers A
    Biochemistry; 2002 Oct; 41(42):12639-51. PubMed ID: 12379106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homology modeling of GLUT4, an insulin regulated facilitated glucose transporter and docking studies with ATP and its inhibitors.
    Mohan S S; Perry JJ; Poulose N; Nair BG; Anilkumar G
    J Biomol Struct Dyn; 2009 Feb; 26(4):455-64. PubMed ID: 19108584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caffeine inhibits glucose transport by binding at the GLUT1 nucleotide-binding site.
    Sage JM; Cura AJ; Lloyd KP; Carruthers A
    Am J Physiol Cell Physiol; 2015 May; 308(10):C827-34. PubMed ID: 25715702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Model of the 3-D structure of the GLUT3 glucose transporter and molecular dynamics simulation of glucose transport.
    Dwyer DS
    Proteins; 2001 Mar; 42(4):531-41. PubMed ID: 11170207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ATP-dependent substrate occlusion by the human erythrocyte sugar transporter.
    Heard KS; Fidyk N; Carruthers A
    Biochemistry; 2000 Mar; 39(11):3005-14. PubMed ID: 10715121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of erythrocyte-(GLUT1), liver-(GLUT2), and adipocyte-type (GLUT4) glucose transporters by binding of the inhibitory ligands cytochalasin B, forskolin, dipyridamole, and isobutylmethylxanthine.
    Hellwig B; Joost HG
    Mol Pharmacol; 1991 Sep; 40(3):383-9. PubMed ID: 1716731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stop-flow analysis of cooperative interactions between GLUT1 sugar import and export sites.
    Sultzman LA; Carruthers A
    Biochemistry; 1999 May; 38(20):6640-50. PubMed ID: 10350483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genistein directly inhibits GLUT4-mediated glucose uptake in 3T3-L1 adipocytes.
    Bazuine M; van den Broek PJ; Maassen JA
    Biochem Biophys Res Commun; 2005 Jan; 326(2):511-4. PubMed ID: 15582607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cysteine-scanning mutagenesis of flanking regions at the boundary between external loop I or IV and transmembrane segment II or VII in the GLUT1 glucose transporter.
    Olsowski A; Monden I; Keller K
    Biochemistry; 1998 Jul; 37(30):10738-45. PubMed ID: 9692964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allosteric silencing of activating function 1 in the 4-hydroxytamoxifen estrogen receptor complex is induced by substituting glycine for aspartate at amino acid 351.
    MacGregor Schafer J; Liu H; Bentrem DJ; Zapf JW; Jordan VC
    Cancer Res; 2000 Sep; 60(18):5097-105. PubMed ID: 11016635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct inhibition of the hexose transporter GLUT1 by tyrosine kinase inhibitors.
    Vera JC; Reyes AM; Velásquez FV; Rivas CI; Zhang RH; Strobel P; Slebe JC; Núñez-Alarcón J; Golde DW
    Biochemistry; 2001 Jan; 40(3):777-90. PubMed ID: 11170395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immobilized membrane vesicle or proteoliposome affinity chromatography. Frontal analysis of interactions of cytochalasin B and D-glucose with the human red cell glucose transporter.
    Brekkan E; Lundqvist A; Lundahl P
    Biochemistry; 1996 Sep; 35(37):12141-5. PubMed ID: 8810921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.